Skip to main content
SpringerLink
Log in

Biobanks as Producers of Reference Materials

  • Chapter
  • First Online:
Biobanking of Human Biospecimens

  • 883 Accesses

Abstract

As diagnostics and clinical research increase in complexity and inter-dependency, there is an increasing need in the diagnostic and pharmaceutical industries for formal certification of clinical biospecimens for nominal properties, so as to be considered Reference Materials. Certified clinical biospecimens that are collected, processed, characterized, stored and distributed by biobanks will facilitate diagnostic test development, evaluation and quality assurance, raising and harmonizing the standards of regulatory submissions based on clinical biospecimen analysis. For clinical biospecimens, certification relates to qualitative and/or quantitative characteristics of diagnosis (clinical, biological and pathological). For certification, biospecimen purity, characterization, fitness-for-purpose, homogeneity and stability, must be evaluated and thoroughly documented. Much of this data is currently collected by biobanks, however formal requirements are needed and biobanks themselves should be accredited to attribute reference material status by adhering to ISO 17034 requirements. This chapter describes potential biospecimen certification, and illustrates the certification process with some examples, which have been published in Biopreservation and Biobanking 2014; 12:113–120.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. International Organization for Standardization Conformity Assessment General Requirements for the Competence of Reference Material Producers. ISO 17034:2016

    Google Scholar 

  2. European Medicines Agency Committee for Medicinal Products for Human Use (2010) Reflection paper on co-development of pharmacogenomic biomarkers and assays in the context of drug development. EMA/CHMP/641298/2008

    Google Scholar 

  3. European Commission (2012) Proposal for a regulation of the European Parliament and of the council on in vitro diagnostic medical devices. COM 2012/0267

    Google Scholar 

  4. Betsou F, Lehmann S, Ashton G et al (2010) Standard preanalytical coding for biospecimens: defining the sample PREanalytical code. Cancer Epidemiol Biomark Prev 19:1004–1011

    Article  CAS  Google Scholar 

  5. Moore HM, Kelly AB, Jewell SD et al (2011) Biospecimen reporting for improved study quality. Biopreserv Biobank 9:57–70

    Article  PubMed  PubMed Central  Google Scholar 

  6. Lehmann S, Guadagni F, Moore H et al (2012) Standard preanalytical coding for biospecimens: review and implementation of the Sample PREanalytical Code (SPREC). Biopreserv Biobank 10:366–374

    Article  PubMed  Google Scholar 

  7. Robb JA, Gulley ML, Fitzgibbons PL et al (2014) A call to standardize preanalytic data elements for biospecimens. Arch Pathol Lab Med 138:526–537

    Article  PubMed  Google Scholar 

  8. Diamandis EP (2010) Cancer biomarkers: can we turn recent failures into successes? J Natl Cancer Inst 102:1462–1467

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Nordin G, Dybkaer R, Forsum U et al (2010) An outline for a vocabulary of nominal properties and examinations—basic and general concepts and associated terms. Clin Chem Lab Med 48:1553–1566

    Article  CAS  PubMed  Google Scholar 

  10. Radouani F, Maille J, Betsou F (2007) Serological profiling with Chlamycheck, a commercial multiplex recombinant antigen Western blot assay of chlamydial infections. Can J Microbiol 53:1360–1368

    Article  CAS  PubMed  Google Scholar 

  11. Chernesky MA (2005) The laboratory diagnosis of Chlamydia trachomatis infections. Can J Infect Dis Med Microbiol 16:15–25

    Google Scholar 

  12. Dirks WG, Frexler HG (2005) Authentication of scientific human cell lines: easy-to-use DNA fingerprinting. Methods Mol Biol 290:35–50

    CAS  PubMed  Google Scholar 

  13. Reid Y, Mintzer J (2012) The current state of cell contamination and authentication—and what it means to biobanks. Biopreserv Biobank 10:236–238

    Article  PubMed  Google Scholar 

  14. Lengellé J, Panopoulos E, Betsou F (2008) Soluble CD40-ligand as a biomarker for storage-related preanalytic variations of human serum. Cytokine 44:275–282

    Article  PubMed  Google Scholar 

  15. Travis WD, Brambilla E, Muller-Hermelink HK et al (eds) (2004) WHO classification of tumours. Tumours of the lung, pleura, thymus and heart. IARC press, Lyon, p 35

    Google Scholar 

  16. Sobin LH, Gospodarowicz MK, Wittekind C (eds) (2009) International Union against Cancer (UICC): TNM classification of malignant tumours, 6th edn. Wiley, New York

    Google Scholar 

  17. Rami-Porta R, Crowley JJ, Goldstraw P (2009) The revised classification TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg 15:4–9

    PubMed  Google Scholar 

  18. Mitelman F, Johansson B, Mertens F (2003) Mitelman database of chromosome aberrations in cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman. Accessed 4 July 2016

  19. Kofanova O, Betsou F (2014) DNA fingerprinting: a quality control case study for human biospecimen authentication. Biopreserv Biobank 12:151–153

    Article  PubMed  PubMed Central  Google Scholar 

  20. van Beers EH, Joosse SA, Ligtenberg MJ et al (2006) A multiplex PCR predictor for aCGH success of FFPE samples. Br J Cancer 94:333–337

    Article  PubMed  PubMed Central  Google Scholar 

  21. Nolan T, Hands RE, Ogunkolade W et al (2006) SPUD: a quantitative PCR assay for the detection of inhibitors in nucleic acid preparations. Anal Biochem 351:308–310

    Article  CAS  PubMed  Google Scholar 

  22. Hughes AJ, Daniel SE, Kilford L et al (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease. A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Berg D, Lang AE, Postuma RB et al (2013) Changing the research criteria for the diagnosis of Parkinson’s disease: obstacles and opportunities. Lancet Neurol 12:514–524

    Article  PubMed  Google Scholar 

  24. Goetz GC, Tilley BC, Shaftman SR et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170

    Article  PubMed  Google Scholar 

  25. Reiber H, Peter JB (2001) Cerebrospinal fluid analysis—disease related data patterns and evaluation programs. J Neurol Sci 184:101–122

    Article  CAS  PubMed  Google Scholar 

  26. Reiber H, Otto M, Trendelenburg C et al (2001) Reporting cerebrospinal fluid data—knowledge base and interpretation software. Clin Chem Lab Med 39:324–332

    Article  CAS  PubMed  Google Scholar 

  27. Parnetti L, Castrioto A, Chiasserini D et al (2013) Cerebrospinal fluid biomarkers in Parkinson disease. Nat Rev Neurol 9:131–140

    Article  CAS  PubMed  Google Scholar 

  28. Teunissen CE, Petzold A, Bennett JL et al (2009) A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology 73:1914–1922

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Hay RJ (2002) Cell quantitation and characterization. In: Atala A, Lanza RP (eds) Methods of tissue engineering. Academic, San Diego, pp 55–84

    Google Scholar 

  30. Council of Europe (2007) European pharmacopoeia: published in accordance with the convention on the elaboration of a European pharmacopeia (European Treaty Series No. 50) 5.8–2.6.7

    Google Scholar 

  31. Romano P, Manniello A, Aresu O et al (2009) Cell line Data Base: structure and recent improvements towards molecular authentication of human cell lines. Nucleic Acids Res 37:D925–D932

    Article  CAS  PubMed  Google Scholar 

  32. Freshney RI (2002) Cell line provenance. Cytotechnology 39:55–67

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Deer EL, Gonzalez-Hernandez J, Coursen JD et al (2010) Phenotype and genotype of pancreatic cancer cell lines. Pancreas 39:425–435

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Van Iwaarden P, Meeus N, Corbisier P (2007) Certification of a reference material of purified genomic DNA from Campylobacter jejuni (NCTC 113351)—IRMM448. Publications Office of the European Union, LU, EUR 22504 EN. ISBN 92–79–03469-3

    Google Scholar 

  35. No authors listed (2012) 2012 ISBER best practices for repositories collection, storage, retrieval, and distribution of biological materials for research international society for biological and environmental repositories. Biopreserv Biobank 10:79–161

    Google Scholar 

  36. Betsou F, ISBER Biospecimen Science Working Group (2016) Assays for qualification and quality stratification of clinical biospecimens used in research: a technical report from the ISBER Biospecimen Science Working Group. Biopreserv Biobank 14(5):398–409. doi:10.1089/bio.2016.0018

    Article  PubMed  Google Scholar 

  37. Betsou F, Luzergues A, Carter A et al (2007) Towards norms for accreditation of biobanks for human health and medical research: compilation of existing guidelines into an ISO certification/accreditation norm-compatible format. Qual Assur J 11:221–294

    Article  Google Scholar 

  38. International Organization for Standardization (2009) ISO15194:2009—in vitro diagnostic medical devices—measurement of quantities in samples of biological origin—requirements for certified reference materials and the content of supporting documentation

    Google Scholar 

Download references

Acknowledgements

The author is grateful to Laurent Antunes, Pieter Visser, Barbara Parodi and Rosanna Peeling for their review of chapter content.

Author information

Authors and Affiliations

  1. IBBL (Integrated Biobank of Luxembourg), 6 rue Ernest Barblé, Luxembourg, 1210, Luxembourg

    Fay Betsou

Authors
  1. Fay Betsou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fay Betsou .

Editor information

Editors and Affiliations

  1. Cancer Research, Institute for Advanced Biosciences, Inserm U1209 CNRS UMR 5309, Université Grenoble-Alpes, Grenoble, France

    Pierre Hainaut

  2. International Prevention Research Institute, Biopreservation and Biobanking, Kensington, Maryland, USA

    Jim Vaught

  3. Institute of Pathology, Medical University of Graz, Auenbruggerplatz 25, A-8036, Graz, Austria

    Kurt Zatloukal

  4. Biobanking and Biomolecular resources Research Infrastructure (BBMRI-ERIC), Graz, Austria

    Markus Pasterk

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Betsou, F. (2017). Biobanks as Producers of Reference Materials. In: Hainaut, P., Vaught, J., Zatloukal, K., Pasterk, M. (eds) Biobanking of Human Biospecimens. Springer, Cham. https://doi.org/10.1007/978-3-319-55120-3_5

Download citation

Publish with us

Policies and ethics

Search

Navigation